Zimmer Biomet (ZBH) received the CE Mark for its Persona Revision Knee System. This addition to the Persona family builds on Zimmer Biomet’s commitment to personalized solutions, providing surgeons ...
Zimmer Biomet Holdings (($ZBH)) announced an update on their ongoing clinical study. Zimmer Biomet Holdings has announced a new pilot study, ...
Zimmer Biomet has scored an FDA clearance for a new component of its total knee replacement offering, aimed at patients who may be sensitive to certain metals or bone cement. The Persona SoluTion ...
"For younger and more active patients, the Oxford Cementless Partial Knee amplifies the benefits of a traditional partial knee replacement by offering knee flexion that resembles natural knee movement ...
Noblesville-based Indiana Orthopedic Institute is an early adopter of a “cementless” partial knee replacement system recently launched in the United States but has long been used in Europe and ...
TipRanks on MSN
Zimmer Biomet’s Knee Implant Study: A Market Game-Changer?
Zimmer Biomet Holdings (($ZBH)) announced an update on their ongoing clinical study. The Persona OsseoTi Keel Compatibility Study, officially ...
May 2 (Reuters) - Medtech firm Zimmer Biomet Holdings (ZBH.N), opens new tab beat Wall Street estimates for first-quarter profit on Thursday, on the back of robust demand for its devices that are used ...
WARSAW, Ind., and ZURICH, Nov. 18, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE: ZBH and SIX: ZBH), a global medical technology leader, today received the CE Mark for its Persona® Revision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback